慢性阻塞性肺疾病合并心血管疾病的治疗体会

Experience in the Treatment of Chronic Obstructive Pulmonary Disease Complicated With Cardiovascular Disease

目的分析慢性阻塞性肺疾病合并心血管疾病的临床治疗方法。方法选取我院收治的患有慢性阻塞性肺疾病合并心血管疾病患者96例作为研究对象,并随机分为两组,每组48例。对照组采用常规治疗方法,观察组在对照组的基础上采用美托洛尔进行治疗。结果两组患者的心率、血压治疗后均具有明显的改善,相比于对照组,观察组的改善效果更为明显,组间差异具有统计学意义(P<0.05)。观察组总有效率为93.75%,高于对照组的79.17%,组间差异具有统计学意义(P<0.05)。结论在治疗慢性阻塞性肺疾病合并心血管疾病方面,美托洛尔治疗效果显著。

Objective To analyze the clinical treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease. Methods A total of 96 patients with chronic obstructive pulmonary disease complicated with cardiovascular diseases in our hospital were enrolled in this study. They were randomly divided into two groups, 48 cases in each group. The control group was treated with conventional treatment, and the observation group was treated with metoprolol on the basis of the control group. Results The heart rate and blood pressure were significantly improved in both groups. Compared with the control group, the improvement effect of the observation group was more obvious, and the difference between groups was statistically significant （P 〈 0.05）. The total effective rate of the observation group was 93.75%, significantly higher than that of 79.17% in the control group, and the difference between the two groups was statistically significant （P 〈 0.05）. Conclusion Metoprolol in the treatment of chronic obstructive pulmonary disease combined with cardiovascular disease is remarkable.